A novel PNPLA2 mutation causing total loss of RNA and protein expression in two NLSDM siblings with early onset but slowly progressive severe myopathy

Angelini, 2019, Metabolic lipid muscle disorders: biomarkers and treatment, Ther Adv Neurol Disord, 12, 10.1177/1756286419843359 Fischer, 2007, The gene encoding adipose triglyceride lipase (PNPLA2) is mutated in neutral lipid storage disease with myopathy, Nat Genet, 39, 28, 10.1038/ng1951 Missaglia, 2019, Neutral lipid storage diseases as cellular model to study lipid droplet function, Cells, 8, 10.3390/cells8020187 Schweiger, 2009, Neutral lipid storage disease: genetic disorders caused by mutations in adipose triglyceride lipase/PNPLA2 or CGI-58/ABHD5, Am J Physiol Endocrinol Metab, 297, 10.1152/ajpendo.00099.2009 Martinez-Lopez, 2016, Autophagy in the CNS and periphery coordinate lipophagy and lipolysis in the Brown adipose tissue and liver, Cell Metab, 23, 113, 10.1016/j.cmet.2015.10.008 Campagna, 2008, Novel mutations in the adipose triglyceride lipase gene causing neutral lipid storage disease with myopathy, Biochem Biophys Res Commun, 377, 843, 10.1016/j.bbrc.2008.10.081 Kobayashi, 2008, The lack of the C-terminal domain of adipose triglyceride lipase causes neutral lipid storage disease through impaired interactions with lipid droplets, J Clin Endocrinol Metab, 93, 2877, 10.1210/jc.2007-2247 Chen, 2010, A novel PNPLA2 mutation causes neutral lipid storage disease with myopathy (NLSDM) presenting muscular dystrophic features with lipid storage and rimmed vacuoles, Clin Neuropathol, 29, 351, 10.5414/NPP29351 Akman, 2010, Neutral lipid storage disease with subclinical myopathy due to a retrotransposal insertion in the PNPLA2 gene, Neuromuscul Disord, 20, 397, 10.1016/j.nmd.2010.04.004 Lin, 2012, Novel PNPLA2 gene mutations in Chinese Han patients causing neutral lipid storage disease with myopathy, J Hum Genet, 57, 679, 10.1038/jhg.2012.84 Tavian, 2012, Contribution of novel ATGL missense mutations to the clinical phenotype of NLSD-M: a strikingly low amount of lipase activity may preserve cardiac function, Hum Mol Genet, 21, 5318, 10.1093/hmg/dds388 Hirano, 2014, Genetic mutations in the adipose triglyceride lipase and myocardial overexpression of peroxisome proliferated activated receptor- in patients with triglyceride deposit cardiomyovasculopathy, Biochem Biophys Res Commun, 443, 574, 10.1016/j.bbrc.2013.12.003 Pasanisi, 2016, Severe cardiomyopathy in a young patient with complete deficiency of adipose triglyceride lipase due to a novel mutation in PNPLA2 gene, Int J Cardiol, 207, 165, 10.1016/j.ijcard.2016.01.137 Missaglia, 2017, Late onset of neutral lipid storage disease due to novel PNPLA2 mutations causing a total loss of lipase activity in a patient with myopathy and slight cardiac involvement, Neuromuscul Disord, 27, 481, 10.1016/j.nmd.2017.01.011 Pennisi, 2017, Neutral Lipid Storage Diseases: clinical/genetic features and natural history in a large cohort of Italian patients, Orphanet J Rare Dis, 12, 10.1186/s13023-017-0646-9 Pennisi, 2015, A myopathy with unusual features caused by PNPLA2 gene mutations, Muscle Nerve, 51, 609, 10.1002/mus.24477 Missaglia, 2015, Novel missense mutations in PNPLA2 causing late onset and clinical heterogeneity of neutral lipid storage disease with myopathy in three siblings, Mol Genet Metab, 115, 110, 10.1016/j.ymgme.2015.05.001 Coassin, 2010, Investigation and functional characterization of rare genetic variants in the adipose triglyceride lipase in a large healthy working population, PLoS Genet, 6, 10.1371/journal.pgen.1001239 Reilich, 2011, The phenotypic spectrum of neutral lipid storage myopathy due to mutations in the PNPLA2 gene, J Neurol, 258, 1987, 10.1007/s00415-011-6055-4 Higashi, 2015, Distinct cardiac phenotype between two homozygotes born in a village with accumulation of a genetic deficiency of adipose triglyceride lipase, Int J Cardiol, 192, 30, 10.1016/j.ijcard.2015.05.004 Missaglia, 2014, Early onset of Chanarin-Dorfman syndrome with severe liver involvement in a patient with a complex rearrangement of ABHD5 promoter, BMC Med Genet, 15, 10.1186/1471-2350-15-32 Abramowicz, 2018, Splicing mutations in human genetic disorders: examples, detection, and confirmation, J Appl Genet, 59, 253, 10.1007/s13353-018-0444-7 Vaz-Drago, 2017, Deep intronic mutations and human disease, Hum Genet, 136, 1093, 10.1007/s00439-017-1809-4 Xu, 2015, Muscle MRI in neutral lipid storage disease with myopathy carrying mutationc 187+1G>A, Musc Nerve, 51, 922, 10.1002/mus.24507 Riordan, 2017, Modifier genes, Network resilience, and the genetics of health, Am J Hum Genet, 101, 177, 10.1016/j.ajhg.2017.06.004 Palmisano, 2018, Sex differences in lipid and lipoprotein metabolism, Mol Metab, 15, 45, 10.1016/j.molmet.2018.05.008 Mauvais-Jarvis, 2013, The role of estrogens in control of energy balance and glucose homeostasis, Endocr Rev, 34, 309, 10.1210/er.2012-1055 Aseer, 2014, Gender-dimorphic regulation of muscular proteins in response to high fat diet and sex steroid hormones, Biotechnol Bioproc Eng, 19, 811, 10.1007/s12257-014-0378-9 Daemen, 2018, The effect of diet and exercise on lipid droplet dynamics in human muscle tissue, J Exp Biol, 221